In a new clinical trial, people with obesity and knee osteoarthritis who took an experimental drug from Eli Lilly lost large ...

Genicular Artery Embolization (GAE) represents a new paradigm in treating knee osteoarthritis that had hitherto been handled ...

Organogenesis Holdings ($ORGO) announced an update on their ongoing clinical study. Study Overview Organogenesis Holdings (ORGO) is sponsoring a ...

Exercise, weight management and physiotherapy are common approaches recommended by medics, to help treat arthritis, but it is ...

Osteoarthritis (OA) remains one of the leading causes of disability worldwide, burdening health systems and diminishing quality of life ...

RejuvaCare Reports Growing Consumer Interest in At-Home Heated Knee Support as Seasonal Joint Discomfort Prompts Search for ...

Paradigm Biopharmaceuticals ( ($AU:PAR) ) has shared an announcement. Paradigm Biopharmaceuticals has confirmed it has enrolled or randomised ...

A new stem cell–based therapy challenges traditional pain treatment by using pain-sensing neurons to reduce inflammation and protect joints. Newly released preclinical data describes an unconventional ...

Khaberni - Recent research indicates that an ancient Brazilian herb may help alleviate debilitating knee pain associated with arthritis. Exercise, weight management, and physical therapy are common ...

Ipsen (Euronext: IPN; ADR: IPSEY) today announced that the pivotal Phase II FALKON trial did not meet its primary endpoint of reducing new heterotopic ossification (HO) in adults and children living ...

Eli Lilly hiked its revenue growth guidance by 7%, while Novo Nordisk was forced to slash its targets by ~12%. See why I'm still bullish on LLY stock.